Clinical Trial Update: A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated DS-8500a in Japanese adults with type 2 diabetes mellitus who were receiving sitagliptin; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DS-8500a
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED